-
1دورية أكاديمية
المؤلفون: Mbaba M; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Golding TM; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Omondi RO; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Mohunlal R; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Egan TJ; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Reader J; Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, 0028, South Africa., Birkholtz LM; Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, 0028, South Africa., Smith GS; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa. Electronic address: gregory.smith@uct.ac.za.
المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116429. Date of Electronic Publication: 2024 Apr 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials*/pharmacology , Antimalarials*/chemistry , Antimalarials*/chemical synthesis , Ferrous Compounds*/chemistry , Ferrous Compounds*/pharmacology , Plasmodium falciparum*/drug effects , Metallocenes*/chemistry , Metallocenes*/pharmacology , Amodiaquine*/pharmacology , Amodiaquine*/chemistry, Structure-Activity Relationship ; Molecular Structure ; Humans ; Parasitic Sensitivity Tests ; Dose-Response Relationship, Drug
-
2دورية أكاديمية
المؤلفون: Okore W; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.; Department of Biomedical Sciences and Technology, Maseno University, Kisumu, Kenya., Ouma C; Department of Biomedical Sciences and Technology, Maseno University, Kisumu, Kenya., Okoth RO; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Yeda R; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Ingasia LO; Sydney Brenner Institute of Molecular Biosciences, University of Witwatersrand, Johannesburg, South Africa., Mwakio EW; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Ochora DO; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.; Department of Biological Sciences, Kisii University, Kisii, Kenya., Wakoli DM; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.; Department of Biochemistry and Molecular Biology, Egerton University, Njoro, Kenya., Amwoma JG; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.; Department of Biological Sciences, University of Embu, Embu, Kenya., Chemwor GC; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Juma JA; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Okudo CO; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Cheruiyot AC; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Opot BH; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Juma D; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Egbo TE; United States Army Medical Research Directorate-Africa (USAMRD-A), Kisumu, Kenya., Andagalu B; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya., Roth A; Medical Communications for Combat Casualty Care, Fort Detrick, Maryland, United States of America., Kamau E; Department of Pathology and Area Laboratory Services, Tripler Army Medical Center, Honolulu, Honolulu, United States of America., Akala HM; Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.
المصدر: PloS one [PLoS One] 2024 Jun 20; Vol. 19 (6), pp. e0298585. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials*/pharmacology , Antimalarials*/therapeutic use , Plasmodium falciparum*/drug effects , Plasmodium falciparum*/genetics , Artemether, Lumefantrine Drug Combination*/therapeutic use , Malaria, Falciparum*/drug therapy , Malaria, Falciparum*/parasitology , Polymorphism, Single Nucleotide*, Humans ; Multidrug Resistance-Associated Proteins/genetics ; Kenya ; Mefloquine/pharmacology ; Mefloquine/therapeutic use ; Amodiaquine/pharmacology ; Amodiaquine/therapeutic use ; Drug Resistance/genetics ; Artemisinins/pharmacology ; Artemisinins/therapeutic use ; Chloroquine/pharmacology ; Chloroquine/therapeutic use ; Quinine/pharmacology ; Quinine/therapeutic use ; Male ; Female
-
3دورية أكاديمية
عنوان ترانسليتريتد: Efficacité thérapeutique et sécurité de l’artésunate + amodiaquine et de l’artéméther + luméfantrine pour le traitement du paludisme simple à Plasmodium falciparum chez les enfants sur la côte sud-est pluvieuse de Madagascar.
المؤلفون: Irinantenaina J; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Carn G; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar - Drugs for Neglected Diseases initiative (DNDi), 1202, Geneva, Switzerland., Randriamiarinjatovo DNAL; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Harimanana AN; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Razanatsiorimalala S; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Ralemary N; Direction Régionale de la Santé Publique Atsimo Atsinana, Farafangana, 309, Madagascar., Randriarison M; Service de Santé de District de Santé Publique, Mananjary, 317, Madagascar., Razafinjato C; National Malaria Control Program, Ministry of Health, Antananarivo, 101, Madagascar., Hotahiene R; Direction de Lutte contre les Maladies Transmissibles, Ministère de la santé publique, Antananarivo, 101, Madagascar., Randrianarivelojosia M; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar - Faculté des Sciences, Université de Toliara, Toliara, 601, Madagascar.
المصدر: Parasite (Paris, France) [Parasite] 2023; Vol. 30, pp. 32. Date of Electronic Publication: 2023 Aug 30.
نوع المنشور: Randomized Controlled Trial; Journal Article
بيانات الدورية: Publisher: Princeps Editions Country of Publication: France NLM ID: 9437094 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-1042 (Electronic) Linking ISSN: 1252607X NLM ISO Abbreviation: Parasite Subsets: MEDLINE
مواضيع طبية MeSH: Amodiaquine*/adverse effects , Malaria, Falciparum*/drug therapy, Humans ; Child ; Artesunate ; Madagascar ; Artemether, Lumefantrine Drug Combination
-
4دورية أكاديمية
المؤلفون: Ngasala BE; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. bngasala70@gmail.com., Chiduo MG; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania., Mmbando BP; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania., Francis FT; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania., Bushukatale S; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Makene T; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mandara CI; National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania., Ishengoma DS; National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania., Kamugisha E; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania., Ahmed M; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania., Mahende MK; Ifakara Health Institute, Dar-es-Salaam, Tanzania., Kavishe RA; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania., Muro F; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania., Molteni F; National Malaria Control Program, Dodoma, Tanzania., Reaves E; U.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Kitojo C; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania., Greer G; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania., Nyinondi S; R.T.I. International, Dar es Salaam, Tanzania., Kabula B; R.T.I. International, Dar es Salaam, Tanzania., Lalji S; R.T.I. International, Dar es Salaam, Tanzania., Chacky F; National Malaria Control Program, Dodoma, Tanzania., Njau RJ; Muhimbili University of Health and Allied Science, Dar es Salaam, Tanzania., Warsame M; Gothenburg University, Gothenburg, Sweden., Mohamed A; National Malaria Control Program, Dodoma, Tanzania.
المصدر: Malaria journal [Malar J] 2024 Apr 09; Vol. 23 (1), pp. 101. Date of Electronic Publication: 2024 Apr 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials*/adverse effects , Malaria, Falciparum*/drug therapy , Artemisinins*/adverse effects , Malaria*/drug therapy, Child ; Humans ; Infant ; Artemether, Lumefantrine Drug Combination/adverse effects ; Tanzania ; Reinfection/chemically induced ; Reinfection/drug therapy ; Prospective Studies ; Drug Combinations ; Artemether/therapeutic use ; Amodiaquine/therapeutic use ; Treatment Outcome ; Plasmodium falciparum
-
5دورية أكاديمية
المؤلفون: Dimbu PR; National Malaria Control Program, Ministry of Health, Luanda, Angola., Labuda S; United States President's Malaria Initiative, United States Centers for Disease Control and Prevention, Luanda, Angola., Ferreira CM; PSI Angola, Luanda, Angola., Caquece F; Field Epidemiology Training Program, Ministry of Health, Luanda, Angola., André K; Field Epidemiology Training Program, Ministry of Health, Luanda, Angola., Pembele G; National Institute of Health Research, Ministry of Health, Luanda, Angola., Pode D; Field Epidemiology Training Program, Ministry of Health, Luanda, Angola., João MF; National Malaria Control Program, Ministry of Health, Luanda, Angola., Pelenda VM; PSI Angola, Luanda, Angola., Nieto Andrade B; PSI Angola, Luanda, Angola., Horton B; United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kennedy C; United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Svigel SS; United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Zhou Z; United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Morais JFM; PSI Angola, Luanda, Angola., Rosário Jd; United States President's Malaria Initiative, USAID, Luanda, Angola., Fortes F; Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal., Martins JF; National Malaria Control Program, Ministry of Health, Luanda, Angola., Plucinski MM; United States President's Malaria Initiative, Malaria Branch, United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Apr 03; Vol. 68 (4), pp. e0152523. Date of Electronic Publication: 2024 Feb 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials*/therapeutic use , Artemisinins*/therapeutic use , Malaria, Falciparum*/drug therapy, Child ; Humans ; Artesunate/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Angola ; Artemether/therapeutic use ; Amodiaquine/therapeutic use ; Drug Combinations ; Plasmodium falciparum
-
6دورية أكاديمية
المؤلفون: Ngasala B; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania., Bushukatale S; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania., Chiduo M; National Institute for Medical Research, Tanga Research Centre, P.O Box 5004, Tanga, Tanzania., Makene T; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania., Mkony L; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania., Mohamed A; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania., Molteni F; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania., Chacky F; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania., Njau RJA; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania., Mwaiswelo R; Department of Microbiology, Immunology, and Parasitology, Faculty of Medicine, Hubert Kairuki Memorial University, P.O Box 65300, Dar es Salaam, Tanzania. richiemwai@yahoo.com.
المصدر: Malaria journal [Malar J] 2024 Mar 29; Vol. 23 (1), pp. 90. Date of Electronic Publication: 2024 Mar 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials* , Malaria, Falciparum*/drug therapy , Artemisinins* , Malaria*/drug therapy, Child ; Humans ; Infant ; Amodiaquine ; Artesunate/therapeutic use ; Tanzania ; Plasmodium falciparum ; Drug Combinations
-
7دورية أكاديمية
المؤلفون: Islam S; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, 22060, Pakistan., Shahzad SA; Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, 22060, Pakistan., Hassan Bin Asad MH; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, 22060, Pakistan., Mannan A; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, 22060, Pakistan.
المصدر: Future medicinal chemistry [Future Med Chem] 2023 Dec; Vol. 15 (23), pp. 2165-2179. Date of Electronic Publication: 2023 Nov 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101511162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8927 (Electronic) Linking ISSN: 17568919 NLM ISO Abbreviation: Future Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry, Female ; Humans ; Molecular Structure ; HeLa Cells ; Structure-Activity Relationship ; Amodiaquine/pharmacology ; Spectroscopy, Fourier Transform Infrared ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/chemistry ; Candida albicans ; Microbial Sensitivity Tests ; Molecular Docking Simulation
-
8دورية أكاديمية
المؤلفون: Qian J; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Wang M; College of Food and Bioengineering, Xihua University, Chengdu, 610039, Sichuan, China., Wang Z; College of Biological and Sciences, China Agricultural University, Beijing, 100193, China., Feng R; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Zhang J; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Ye C; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Zhang M; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Wang B; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China. wbaomin@263.net., Cui L; Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 3720 Spectrum Boulevard, Suite 304, Tampa, FL, 33612, USA. liwangcui@usf.edu.
المصدر: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2022 Feb; Vol. 414 (4), pp. 1631-1640. Date of Electronic Publication: 2021 Nov 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE
مواضيع طبية MeSH: Amodiaquine/*blood , Antimalarials/*blood , Enzyme-Linked Immunosorbent Assay/*methods, Amodiaquine/analysis ; Animals ; Antibodies, Immobilized/chemistry ; Antibodies, Monoclonal/chemistry ; Antimalarials/analysis ; Enzyme-Linked Immunosorbent Assay/economics ; Female ; Mice, Inbred BALB C ; Rats ; Time Factors ; Mice
-
9دورية أكاديمية
المؤلفون: Traore K; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Coulibaly D; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Kone AK; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Guindo B; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Traore S; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Kouriba K; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Djimde M; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali., Thera MA; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies, Bamako, Mali.
المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Jan 12; Vol. 229 (1), pp. 189-197.
نوع المنشور: Randomized Controlled Trial; Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Antimalarials*/adverse effects , Malaria*/epidemiology , Piperazines* , Quinolines* , Artemisinins*, Child ; Humans ; Infant ; Child, Preschool ; Mali/epidemiology ; Seasons ; Sulfadoxine/adverse effects ; Amodiaquine/adverse effects ; Drug Combinations ; Chemoprevention/adverse effects
-
10دورية أكاديمية
المؤلفون: Kajubi R; Technical, Malaria Consortium, Kampala, Uganda., Ainsworth J; Technical, Malaria Consortium, London, UK., Baker K; Technical, Malaria Consortium, London, UK.; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden., Richardson S; Technical, Malaria Consortium, London, UK., Bonnington C; Technical, Malaria Consortium, London, UK., Rassi C; Technical, Malaria Consortium, London, UK., Achan J; Technical, Malaria Consortium, London, UK., Magumba G; Technical, Malaria Consortium, Kampala, Uganda., Rubahika D; National Malaria Control Division, Ministry of Health of Uganda, Kampala, Uganda., Nabakooza J; National Malaria Control Division, Ministry of Health of Uganda, Kampala, Uganda., Tibenderana J; Technical, Malaria Consortium, London, UK., Nuwa A; Technical, Malaria Consortium, Kampala, Uganda., Opigo J; National Malaria Control Division, Ministry of Health of Uganda, Kampala, Uganda.
المصدر: Gates open research [Gates Open Res] 2023 Dec 18; Vol. 7, pp. 14. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023).
نوع المنشور: Clinical Trial Protocol; Journal Article
بيانات الدورية: Publisher: Bill and Melinda Gates Foundation Country of Publication: United States NLM ID: 101717821 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-4754 (Electronic) Linking ISSN: 25724754 NLM ISO Abbreviation: Gates Open Res Subsets: MEDLINE
مواضيع طبية MeSH: Malaria*/epidemiology, Child, Preschool ; Humans ; Infant ; Amodiaquine/therapeutic use ; Chemoprevention ; Prospective Studies ; Randomized Controlled Trials as Topic ; Seasons ; Uganda/epidemiology